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Abstract 
 
Background: Cutaneous leishmaniasis (CL) caused by Leishmania major is common in Middle East countries. Most therapies are limited and 
there is no effective vaccine for leishmaniasis. It has been reported that the ancient practice of wet cupping has been effective in treatment of 
drug resistant CL in humans. The purpose of this present study was to evaluate the efficacy of wet-cupping in treatment of L. major infected 
BALB/C mice. 
Methods: We designed a randomized clinical trial using 12 male BALB/c mice, aged 8-10 weeks (six mice for each experimental and control 
group). Each mouse was infected with L. major on the left hind footpad. Mice in the experimental group underwent wet-cupping once a week, up 
to 6 weeks. The appearance of local reaction in the parasite inoculated paw was monitored and footpad thickness was measured for 7 weeks in 
both groups. Then all mice were killed and their spleen and lymph node cells were cultured and the level of IFN- γ and IL-4 of cultured cells 
supernatant were measured as the markers of TH1 and TH2, respectively. 
Results: Lesion size thickness in the intervention mice seemed to grow faster than control ones. There were no significant differences in animal 
weight, spleen and lymph node weight and total cell number. The level of INF-γ and IL-4 produced by spleen cells of intervention mice was not 
significantly different from control mice (p=NS). 
Conclusion: Our study showed that wet-cupping has no significant treatment effect on coetaneous leishmaniasis in BALB/c mice. Interestingly, 
the disease was more severe in the intervention group. 
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Introduction 
 
The protozoan parasite Leishmania causes three main forms of human diseases including cutaneous leishmaniasis, mucocutaneous 
leishmaniasis and visceral leishmaniasis. Cutaneous leishmaniasis (CL) which is caused by Leishmania major (L. major) is a well-established 
experimental model of human disease caused by an intracellular parasite (Yavar et al., 2013).  
The protozoan L. major is an obligate intracellular parasite, which can infect various mammalian hosts such as rodents, dogs, and humans. 
Infection in humans with this protozoan parasite causes a spectrum of clinical manifestations, ranging from limited cutaneous lesion to life-
threatening systemic form (Rai et al., 2013; Badiee et al., 2013).  
Currently there is no effective and safe vaccine for leishmaniasis, and most therapies are limited by toxicity, long-term courses of treatment and 
development of drug resistance (Blum et al., 2012). As a method of countering these limitations, efforts have been made to develop new drugs and 
new methods to augment the immune system or improve the ability of the immune responses (Badiee et al., 2013). 
Wet-cupping has been a treatment technique for some diseases for many thousands of years. There are some non-published reports from the 
Iranian wet-cupping research center with regard to the successful effect of wet-cupping on drug resistant type of CL. To evaluate this effect we 
conducted an experimental study on L. major infected BALB/C mice (Ahmadi et al., 2008).  
 
 
Methods 
Mice 
 
 In this randomized clinical trial 12 male BALB/c mice, aged 8-10 weeks, were used (six mice for each experimental and control 
group). Animals were allowed to acclimatize to the laboratory conditions for at least 2 weeks before experimental manipulation. All mice were 
maintained on a 12-hour light/dark cycle with free access to water and food ad libitum and were housed 6 mice per cage. 
 
Infection protocol and lesion size measuring 
 
L. major parasites were prepared from the Pasteur Institute of Iran and were grown in an RPMI1640 medium supplemented with 20% 
heat-inactivated fetal calf serum, 100 U/ml penicillin, 100 μg/ml streptomycin, 2 mM L-glutamine and 40 mM HEPES. For infection, mice were 
inoculated subcutaneously (SC) in the left hind footpad with 1×106 stationary phase L. major promastigotes at a volume of 50 μl. 
The thickness of the infected footpad and the contralateral uninfected footpad were measured once a week with a venire caliper. The increase in 
footpad thickness was calculated with the Footpad Thickness Index (FTI):  
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Thickness measurements were begun at the time of local reaction appearance and continued for 7 weeks. 
 
Wet-cupping 
 
 Starting at the time of L. major inoculation, wet-cupping was applied on the experimental group (n = 6) (Figure 1), once a week as 
explained. First, mice were anesthetized by ether. Then an area of 2.5 cm on the backs of the mice, between the shoulders, was shaved. The skin 
of the shaved area was vacuumed into the cup (1 ml) for 5 min by manual suction. Next the suctioned area which now had become indurated with 
a dark blue color was punched by a needle and vacuumed for 5 min, to drain the blood accumulated in the area. 
 
Spleen and lymph node cell culture 
 
 Nine weeks after parasite inoculation (7 weeks following appearance of footpad reaction), all mice were killed and their spleen was 
aseptically removed. Single-cell suspension was made by forcing the tissues through a cell strainer with a sterile syringe plunger. Erythrocytes 
were removed using ACK buffer (0.15 M NH4Cl, 1 M KHCO3, 0.01 M Na-EDTA, PH= 7.4), and spleen cells were counted. Popliteal lymph 
nodes (PLN) draining the infected footpad were also harvested and their single cell suspensions were washed and counted. Spleen and PLN cells 
were separately suspended in RPMI containing 10% heat-inactivated fetal calf serum, 100 U/ml penicillin, 100 μg/ml streptomycin, 2 mM L-
glutamine and 40 mM HEPES. Cells were cultured on 96-well culture plates at 5 × 105 cells per well in triplicate in the presence of concanavalin 
A (Con A) or leishmanial antigen for 48 hr. Parasite antigen was prepared by freeze-towing of the parasite five times in liquid nitrogen. Cell 
culture supernatants were removed after 48 hr and stored at -20 for measurement of cytokines. 
 
Cytokine assay 
 
 To evaluate the effect of wet-cupping on the pattern of cytokine production, draining lymph node cells of mice were cultured in the 
presence of Con A and the culture supernatants were assayed for the levels of IFN-γ and IL-4 production. The levels of IL-4 in the supernatant 
were determined by using double-sandwich monoclonal antibody enzyme-linked immunosorbent assay (ELISA) protocol as standardized by BD 
Pharmingen (San Diego, CA). In brief, the anti-IL4 capture monoclonal antibody (mAb) was absorbed on a polystyrene 96-well plate, and the IL-
4 present in the sample was bound to antibody-coated wells. The biotinylated anti-IL-4 detecting mAb was added to bind the IL-4 captured by the 
first antibody. After washing, streptavidin-alkaline phosphatase (Sigma) was added to the wells to detect the biotinylated detecting mAb and 
finally substrate (PNPP, Sigma) was added and a colored product was formed in proportion to amount of IL-4 present in the sample, which was 
measured at an optical density (OD) of 450 nm. Recombinant mouse IL-4 (Pharmingen BD, cat 550067) was used as standard. IFN-γ was 
measured in 48-hour supernatant using a commercial kit (R&D Company). The instruction was similar to the above-mentioned protocol for IL-4, 
except for horse-radish peroxides and TMB substrate, which was used instead of streptavidin-alkaline phosphatase and PNPP, respectively, and 
the resulting color, was read at 405 nm.    
 
Statistic analysis 
 
 Data analysis was performed using the SPSS 22.0 and STATA statistical programs. The following tests were used when appropriate, to 
compare spleen parasite load at both points in time within each mice group and between the two mouse groups, and the relative cytokine levels in 
stimulated and non-stimulated CD4+ and CD8+ T cells, within each group of mice: the Kruskal–Wallis test for k independent samples (k > 2), the 
Wilcoxon signed-ranks test for two matched samples and the Mann–Whitney test for two independent samples. The student t-test and analysis of 
variance (ANOVA) were used for statistical analysis of the footpad lesion size data and the cytokine (IL-4 & IFN-γ) concentration. In all 
statistical tests, a 5% level of significance was used. 
 
 
 
Results 
 
The main result of this study is outlined in Table 1 and Figure 2. There were no significant differences in lesion size and kinetics of 
development between wet-cupping-treated mice and control mice. Meanwhile, FTI (lesion size) in the experimental group seemed to grow faster 
than controls, and it became necrotic sooner. On the other hand, there was no significant difference in animal weight, spleen and PLN weight and 
total cell number of spleen and PLN between intervention and control groups (data not shown). 
Table 1 outlined the result of mean and standard deviation of INF-γ and IL-4  in experimental and control groups. It shows that the level of INF-γ 
and IL-4 produced by spleen cells of wet-cupping-treated mice was not significantly different from those of control mice. 
 
 
Table 1:  Means (standard deviations), Mean difference, 95% confidence interval (CI) and p-value for 
experimental and control groups and comparing both groups (two-tailed tests) 
Measure Intervention 
group 
Control group Mean 
difference 
95% CI P-Value 
Lower Upper 
FTI* 163(71) 113(42) 50 -27 128 0.179 
IFN-γ 2325(2745) 4895(2834) -2570 -9225 4084 0.344 
IL-4 113(83) 70(33) 43 -134 221 0.536 
*
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Figure 1. CONSORT flow diagram 
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Figure 2: The trend of paw thickness in intervention vs. control groups 
 
*Footpad Thickness Index  FTI =
Thickness  of  infected  footpad  – Thickness  of  uninfected  footpad
Thickness  of  uninfected  footpad
× 100 
 
 
 
 
 
  
 
 
Discussion 
 
  Our study showed that wet-cupping has no significant treatment effect on cutaneous leishmaniasis in BALB/c mice, and we 
interestingly observed that the disease was more severe in the experimental group, which was contrary to our expected results. 
Wet-cupping has been reported as an effective treatment for many diseases and disorders such as low back pain (Farhadi et al., 2009; Kim et al, 
2011), neck pain (Kim et al., 2013), tension headache and migraine (Ahmadi et al., 2008), metabolic conditions and LDL level (Niasari et al., 
2007), Herpes Zoster infection and post herpetic neuralgia (Cao et al., 2010). In a study conducted at Harvard University Kwong et al. showed 
that a type of wet-cupping (Gua Sha) has an effect on Heme Oxygenase-1 (HO-1) upregulation. HO-1 is a cell protective agent with some anti-
inflammatory, anti-proliferative, and anti-apoptotic effects. This upregulation is induced by factors such as hydrogen peroxide, hypoxia, UV 
irradiation and physical stresses (see below) (Bach et al. 2005; Lee and Chau, 2002; Otterbein et al., 2003). 
As was explained above, in some non-published reports from Iranian’s wet-cupping research center, wet-cupping had a significant 
treatment effect on drug resistant cutaneous leishmaniasis in humans. But, our study result did not show the same effect in L. major infected mice. 
It is of great interest to mention that there is a persuasive theory with regard to the mechanism of wet-cupping that is known as the “stress 
response” reaction. It has been suggested that most of the wet-cupping effects are caused by this reaction. Stress response is a complex reaction in 
the body after injury and stress. It causes two contrasting effects in the immune system. In some cases, stress response suppresses the immune 
system, but in some others, stress response leads to immune system excitement. 
We suggest two reasons to explain why wet-cupping had no treatment effect on cutaneous leishmaniasis in mice and, in contrast, the disease was 
more severe in the experimental group. First, it seems that stress response suppressed the mice’s immune system, thus the severity of the disease 
was increased in these mice. As we mentioned, a previous study showed that HO-1 that is upregulated by wet-cupping has anti inflammatory 
effects. This mechanism may be a reason for more progressive leishmaniasis in the wet-cupping group of mice (Cao et al., 2010). Second, we 
used ether for anesthesia but its effect on the immune system is unknown and it may be a confounding agent. As we know, pain has a significant 
role in stress response reaction. In humans, no anesthesia is used during wet-cupping, but in our study, we had to anesthetize mice to prevent 
unwanted movements. Studies on other volatile anesthetics have showed no significant effect on stress response (Ihn et al., 2009), but there is no 
study on ether. As ether suppresses pain like opioids, it may suppress immune response and cause more severe disease in the intervention group. 
 
 
Strengths, limitations, and future directions 
 
This study has several methodological strengths. This is the first study in mice to find the effect of wet-cupping in leishmaniasis. We 
used BALB/c mice that are mice strain sensitive to leishmaniasis. Our variables include some immune cytokines similar to IFN-γ and IL-4. And 
we used the RCT method in our study. 
One of the weaknesses of our study is the use of ether as anesthetic agent. Its effect on the immune system is unclear. We suggest Isoflurane for 
future studies with regard to wet-cupping in mice, because it has no effect on stress response. The other limitation of our study was the smallness 
of the sample size with only 6 mice in each group, so we suggest the use of more mice in future studies. 
It seems that the effect of wet-cupping in humans differs from mice. We suggest that future studies are conducted on drug resistant human 
leishmaniasis. 
 
Conclusion 
 
Our study showed no significant effect of wet-cupping in treatment of cutaneous leishmaniasis in BALB/c mice. More wet-cupping 
studies and interventions in human and primates are proposed. Induction of anesthesia by halogenated anesthetics like Isoflurane which has no 
significant effect on stress response can estimate the effect of wet-cupping more accurately. 
Figure 2: The trend of paw thickness in intervention vs control groups  
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